AstraZeneca Vaccine Effective Against COVID Variant Found in the UK, Says Oxford Report 05/02/2021 Raisa Santos The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday. The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading -> WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> US Rejoining COVAX Should Involve More Resources, Says Fauci 05/02/2021 Kerry Cullinan The US decision to join COVAX “is likely to mean resources” to be able to get vaccines for people, Dr Tony Fauci, US President Joe Biden’s Chief Medical Advisor, told the International AIDS Society’s COVID-19 conference this week. Fauci also told the conference that scientists were taking the SARS-COV2 variant identified in South Africa so […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO China Team Visits Lab at Centre of Conspiracies, Fieldwork Proving To Be “Extremely Useful” 05/02/2021 Madeleine Hoecklin The World Health Organization’s (WHO) investigative team in Wuhan, China, visited the biosafety laboratory that has been at the centre of numerous conspiracy theories about the COVID-19 pandemic on Wednesday, making it the most controversial site for the team’s fieldwork so far. The team of 13 experts spent three-and-a-half hours at the Wuhan Institute of […] Continue reading -> US Rejoining COVAX Should Involve More Resources, Says Fauci 05/02/2021 Kerry Cullinan The US decision to join COVAX “is likely to mean resources” to be able to get vaccines for people, Dr Tony Fauci, US President Joe Biden’s Chief Medical Advisor, told the International AIDS Society’s COVID-19 conference this week. Fauci also told the conference that scientists were taking the SARS-COV2 variant identified in South Africa so […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US Rejoining COVAX Should Involve More Resources, Says Fauci 05/02/2021 Kerry Cullinan The US decision to join COVAX “is likely to mean resources” to be able to get vaccines for people, Dr Tony Fauci, US President Joe Biden’s Chief Medical Advisor, told the International AIDS Society’s COVID-19 conference this week. Fauci also told the conference that scientists were taking the SARS-COV2 variant identified in South Africa so […] Continue reading -> Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Five African Countries To Pilot New Short-Course TB Therapy, Which Can Put World On Track To End TB 04/02/2021 Paul Adepoju IBADAN, NIGERIA — A new fixed-dose combination (FDC) tuberculosis (TB) treatment could improve the ease of treatment regimes, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB. The short-course preventative treatment, consisting of two drugs – rifapentine and isoniazid – will reduce the pill burden […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Switzerland Nixes AstraZeneca Vaccine Until More Evidence Is Obtained. Other EU Countries Rule Out Vaccine For Older People 04/02/2021 Madeleine Hoecklin Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Switzerland has become the first European country to reject an application by AstraZeneca for regulatory approval. Meanwhile, half a dozen other European countries have now said that data on the AstraZeneca/Oxford vaccine so far is insufficient to permit its use among people over the age of 65 – with Belgium being the latest. “The data […] Continue reading -> Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Oxford University To Begin Trial On Mixed Vaccines; GSK & CureVac Agree To Develop Vaccine Targeting New Variants 04/02/2021 Madeleine Hoecklin The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Posts navigation Older postsNewer posts